Skip to content

ALPS

ALPS Group, Inc.

NASDAQ · Healthcare · Biotechnology · MY

$0.33
−2.41%
Ask drillr

Year over year

Reported trailing growth

Revenue
—
EBITDA
—
EBIT
—
EPS
—
Free cash flow
—
Operating cash flow
—

Forward estimates

Based on analyst estimates

Revenue
—
EBITDA
—
EPS
—

Three-year CAGR

Revenue
+10.5%
EBITDA
+33.3%
EBIT
-35.2%
Net income
+20.1%
EPS
+0.0%
Free cash flow
-55.5%

Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026